New Weight-Loss drug enters early human testing

NCT ID NCT07152002

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 25 times

Summary

This early-stage study tests a new drug called LY4064912 in healthy volunteers and people with overweight or obesity. The main goal is to see if the drug is safe and what side effects it may cause. Researchers will also measure how the body processes the drug and its effect on body weight. The study involves injections or infusions and frequent blood tests.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Collaborative Neuroscience Network - CNS

    RECRUITING

    Los Alamitos, California, 90720, United States

    Contact Phone: •••-•••-••••

    Contact

  • ICON Early Phase Services

    RECRUITING

    San Antonio, Texas, 78209, United States

    Contact Phone: •••-•••-••••

    Contact

  • Lilly Centre for Clinical Pharmacology

    RECRUITING

    Singapore, 138623, Singapore

    Contact Phone: •••-•••-••••

    Contact

Conditions

Explore the condition pages connected to this study.